1Patsalos PN, Berry DJ, Bourgeois BF, et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring:a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies [ J ]. Epilepsia,2008,49 (7) : 1239-1276.
2Bemus I, Dickinson RG,Hooper WD ,et al. Dose-dependent metabolism of carbamazepine in humans [ J ]. Epilepsy Re.s, 1996,24 : 163-172.
3Hooper WD, Johnson LP. Measurement of anticonvulsants and their metabolites in biological fluids [ A ]. In : Eadie M J, Vajda FJE. Antiepileptic drugs pharmacology and therapeutics [ M]. Vol 138. Berlin:Springer-Verlag,1999. 172-187.
4Rainey PM, Rogers KE, Roberts WL. Metabolite and matrix interference in phenytoin immunoassays [ J ]. Clinical Chemistry, 1996,42 (10) : 1645-1653.
5Contin M,Mohamed S,Candela C ,et al. Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotriglne, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy [ J ]. J Chromatogr B Analyt Technol Biomed Life Sci,2010,878(3-4) :461-465.
6Tomson T, Villen T. Ethoxuximide enantiomers in pregnancy and lactation [ J]. Ther Drug Mo nit , 1994,16:621-623.
7Johannessen SI, Battino D, Berry D J, et al. Therapeutic drug monitoring of the newei antiepileptic drugs [J]. Ther Drug Monit,2003,25(3) :347-363.
8Johannessen SI,Landmark CJ. Value of therapeutic drug monitoring in epilepsy [J]. Expert Rev Neurother ,2008,8( 6 ) :929-939.
9Morrell MJ. Guidelines for the care of women with epilepsy [ J ]. Neurology, 1998,51 : S21-S27.
10Anderson GD. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs [ J]. Ther Drug Monit ,2008,30(2) :173-180.
7Fisher R S, Blum D E, Diventura B, et al. Seizure diaries for clinical research and practice: limitations and future prospects [ J ]. Epilepsy Behav, 2012,24 (3) :304-310.
8Glauser T, Ben-Menachem E, Bourgeois B, et al. Upda- ted ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizuresand syndromes~ Jl. Epilepsia, 2013,54(3) :551-563.
9Guerrini R, Zaceara G, |a Marca G, et al. Safety and tolerability of antiepileptic drug treatment in children with epilepsy[ J]. Drug Saf, 2012,35 (7) :519-533.
